Tempus AI, Inc. Director David R. Epstein Sells Shares

On March 17th, David R. Epstein, a director of Tempus AI, Inc. (NASDAQ:TEM - Get Free Report), sold 990 shares of the company's stock. The shares were sold at an average price of $46.83, totaling a value of $46,361.70. After this sale, Epstein now owns 26,284 shares, which are valued at approximately $1,230,879.72. This transaction represents a 3.63% decrease in his ownership of the stock. The details of the sale were disclosed in a legal filing with the SEC, which is publicly accessible.

Tempus AI Stock Performance

On Wednesday, the stock of Tempus AI increased by 5.0%, rising by $2.29 and reaching $48.03. The trading volume during this time was 11,624,616 shares, which is significantly higher than the average volume of 5,018,028 shares. The company's stock has fluctuated, recording a fifty-two week low of $22.89 and a high of $91.45. In terms of its financial metrics, Tempus AI has a quick ratio of 2.55, a current ratio of 2.69, and a debt-to-equity ratio of 8.17. The firm's fifty-day moving average stands at $55.86, and the two-hundred-day moving average is $51.48.

Analyst Ratings Overview

Recent reports from various analysts have discussed Tempus AI. Loop Capital recently lowered their target price from $57.00 to $52.00 while maintaining a "buy" rating. Meanwhile, William Blair reaffirmed a "market perform" rating. Piper Sandler adjusted their price objective from $70.00 to $55.00, indicating a "neutral" rating. In contrast, Needham & Company LLC raised their target price from $56.00 to $70.00, affirming a "buy" rating. Overall, six analysts have given the stock a hold rating, while another six have suggested a buy. MarketBeat reports a consensus rating of "Moderate Buy," with an average target price of $61.18 for Tempus AI stock.

Institutional Investors and Hedge Funds

Several hedge funds have recently adjusted their holdings in Tempus AI. GSA Capital Partners LLP added a new stake valued at $306,000 in the third quarter. First Horizon Advisors Inc. also entered with a new stake of approximately $30,000. The Manufacturers Life Insurance Company increased its stake by 10.2% and now owns 29,789 shares worth about $1,686,000 after buying an additional 2,765 shares. Captrust Financial Advisors also invested in Tempus AI during this period with a stake valued around $2,726,000. NEA Management Company LLC notably expanded its holdings by 17.8%, acquiring 5,385,979 shares worth $304,846,000. Currently, institutional and hedge fund investors own 24.22% of the stock.

About Tempus AI

Tempus AI Inc is a technology firm at the forefront of advancing precision medicine through artificial intelligence, particularly in healthcare. The company provides AI-driven precision medicine solutions aimed at enabling physicians to deliver tailored patient care, while also facilitating the discovery, development, and delivery of optimal therapeutics.

Tempus, AI, Stocks